This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Discgenics. Active years: 2012-2026.
Location History:
- Memphis, TN (US) (2012 - 2020)
- Centennial, CO (US) (2021)
Company Filing History:
Years Active: 2012-2026
Title: Christopher Duntsch: Innovator in Disc Treatment Technologies
Introduction
Christopher Duntsch is a notable inventor based in Memphis, TN (US), recognized for his contributions to medical technology, particularly in the treatment of degenerative disc disease. With a total of 6 patents, Duntsch has made significant strides in developing innovative solutions for spinal health.
Latest Patents
Duntsch's latest patents include groundbreaking inventions such as methods for the treatment of degenerative disc disease. This invention provides an isolated disc stem cell population, compositions, and methods of obtaining and growing the same. Additionally, it introduces an isolated discosphere, along with methods for obtaining and cultivating these cells. An artificial disc containing the cells of the present invention is also provided, along with methods for its creation. Furthermore, this invention outlines a method for treating subjects with herniated discs using the cells and techniques developed.
Career Highlights
Duntsch has established himself as a key figure in the medical field, particularly through his work at Discgenics. His innovative approaches have the potential to transform the treatment landscape for patients suffering from disc-related ailments.
Collaborations
Some of his notable coworkers include Valery Kukekov and Valery Kukekeov, who have contributed to the collaborative efforts in advancing disc treatment technologies.
Conclusion
Christopher Duntsch's work exemplifies the intersection of innovation and healthcare, showcasing how inventive solutions can lead to improved patient outcomes. His contributions to the field of spinal health are significant and continue to influence medical practices today.